Your reference journal for coronary, valvular and structural interventions

Articles

Editorial

Oct 7, 2022

An ESC/EAPCI consensus paper on percutaneous treatment of acute pulmonary embolism; catheter-directed thrombolysis vs standard anticoagulation therapy in acute pulmonary embolism; pretreatment with evolocumab to prevent periprocedural microvascular dysfunction after PCI; physician and patient perceptions of antithrombotic strategies for AF-PCI; ACh provocative testing for INOCA and MINOCA; long-term results from the RADIANCE-HTN SOLO trial; and more

Capodanno D

free

Editorial

10.4244/EIJ-E-22-00032 • Oct 7, 2022

In search of the pleiotropic effects of PCSK9 inhibitors

Räber L, Ueki Y

free

Editorial

10.4244/EIJ-E-22-00031 • Oct 7, 2022

Two legs to stand on: why acetylcholine testing should be considered along with wire-based tests in the diagnosis of non-obstructive myocardial ischaemia

Escaned J, Mejía-Rentería H

free

Editorial

10.4244/EIJ-E-22-00030 • Oct 7, 2022

Long-term efficacy and safety of renal denervation: another brick for building a hybrid therapy for hypertension?

Volpe M, Gallo G

free

Viewpoint

10.4244/EIJ-E-22-00037 • Oct 7, 2022

What is the future role of cerebral embolic protection in transcatheter aortic valve implantation?

Søndergaard L, Mylotte D, Capodanno D

free

Viewpoint

10.4244/EIJ-D-22-00592 • Oct 7, 2022

Confirming the performance of new coronary stent platforms by systematic registry-based cluster-randomised evaluation of their implementation in clinical practice

Redfors B, Angerås O, Omerovic E

free

Expert consensus

10.4244/EIJ-D-22-00246 • Oct 7, 2022

Percutaneous treatment options for acute pulmonary embolism: a clinical consensus statement by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function and the European Association of Percutaneous Cardiovascular Interventions

Pruszczyk P, Klok F, Kucher N, Roik M, Meneveau N, Sharp AS, Nielsen-Kudsk J, Obradović S, Barco S, Giannini F, Stefanini G, Tarantini G, Konstantinides SV, Dudek D

free

Clinical research

10.4244/EIJ-D-21-01080 • Oct 7, 2022

A pilot randomised trial of catheter-directed thrombolysis or standard anticoagulation for patients with intermediate-high risk acute pulmonary embolism

Kroupa J, Buk M, Weichet J, Malikova H, Bartova L, Linkova H, Ionita O, Kozel M, Motovska Z, Kocka V

free

Clinical research

10.4244/EIJ-D-22-00269 • Oct 7, 2022

Evolocumab for prevention of microvascular dysfunction in patients undergoing percutaneous coronary intervention: the randomised, open-label EVOCATION trial

Ishihara M, Asakura M, Hibi K, Okada K, Shimizu W, Takano H, Suwa S, Fujii K, Okumura Y, Mano T, Tsujita K, Igeta M, Okamoto R, Suna S

free

Clinical research

10.4244/EIJ-D-21-01044 • Oct 7, 2022

Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registry

Chandrasekhar J, Baber U, Sartori S, Goel R, Nicolas J, Vogel B, Snyder C, Kini A, Briguori C, Witzenbichler B, Iakovou I, Sardella G, Marzo K, DeFranco A, Stuckey T, Chieffo A, Colombo A, Shlofmitz RA, Capodanno D, Dangas G, Pocock S, Mehran R

free

Clinical research

10.4244/EIJ-D-21-00971 • Oct 7, 2022

Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries

Montone R, Rinaldi R, Del Buono M, Gurgoglione F, La Vecchia G, Russo M, Caffè A, Burzotta F, Leone AM, Romagnoli E, Sanna T, Pelargonio G, Trani C, Lanza GA, Niccoli G, Crea F

free